ELIZABETH VELASQUEZ: Open Payments
NPI 1225320138 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,096 in 126 payments from 27 companies in 2025. Trend: 2023 $2,208 · 2024 $2,120 · 2025 $2,096
Food & beverage: $2,096
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $353 |
| HARMONY BIOSCIENCES LLC | 6 | $174 |
| UCB, Inc. | 12 | $154 |
| ARGENX US, INC. | 5 | $140 |
| Axsome Therapeutics, Inc. | 5 | $128 |
| Genentech USA, Inc. | 7 | $124 |
| Lundbeck LLC | 6 | $118 |
| PFIZER INC. | 6 | $103 |
| Neurelis, Inc. | 5 | $100 |
| Biogen, Inc. | 5 | $92 |
Products named: UBRELVY, WAKIX, VYVGART HYTRULO, Sunosi, Ocrevus Zunovo, VYEPTI, NURTEC ODT, QULIPTA.
Industry payments across TX — which companies pay providers there.
